Letter to "Levothyroxine absorption test results in patients with TSH elevation resistant to treatment".

Szczegóły
Comments

Tytuł:: Letter to "Levothyroxine absorption test results in patients with TSH elevation resistant to treatment".
Autorzy:: Öztürk S; Department of Internal Medicine, Division of Endocrinology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey. .
Akarsu E; Department of Internal Medicine, Division of Endocrinology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.
Źródło:: Endocrine [Endocrine] 2021 Dec; Vol. 74 (3), pp. 729. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji:: Letter; Comment
Język:: English
Imprint Name(s):: Publication: Feb. 1996- : Totowa, NJ : Humana Press
Original Publication: Houndsmills, Basingstoke, Hants, UK : Macmillan Press, c1994-
MeSH Terms:: Hypothyroidism*/diagnosis
Hypothyroidism*/drug therapy
Thyroxine*
Humans ; Thyrotropin
References:: IlginYildirim Simsir, UtkuErdem Soyaltin, AhmetGokhan Ozgen, Levothyroxine absorption test results in patients with TSH elevation resistant to treatment. Endocrine 64, 118–121 (2019). (PMID: 10.1007/s12020-019-01889-x)
GraceE.Ching Sun et al. The clinical utility of free thyroxine in oral levothyroxine absorption testing. Endocr. Pract. 20, 925–929 (2014). (PMID: 10.4158/EP13487.OR)
KennethB. Ain et al. Pseudomalabsorption of levothyroxine. JAMA 266, 2118–2120 (1991). (PMID: 10.1001/jama.1991.03470150090036)
Substance Nomenclature:: 9002-71-5 (Thyrotropin)
Q51BO43MG4 (Thyroxine)
Entry Date(s):: Date Created: 20210720 Date Completed: 20211122 Latest Revision: 20211203
Update Code:: 20240105
PubMed Central ID:: PMC8571230
DOI:: 10.1007/s12020-021-02808-9
PMID:: 34283384
: Opinia redakcyjna

Full Text Finder

Comment on: Endocrine. 2019 Apr;64(1):118-121. (PMID: 30868414)
Comment in: Endocrine. 2021 Dec;74(3):730. (PMID: 34468948)

Informacja